Clinical Trial Translation

Informed Consent Form Translation Services for Global Clinical Trials

Support clear participant communication with informed consent form translation designed for multinational clinical research.

Sesen helps pharmaceutical, biotechnology, medical device, and CRO teams translate informed consent forms and related participant materials with careful attention to clinical meaning, patient readability, study terminology, reviewer feedback, and version control.

Informed Consent Form (ICF) Translation Services
150+ Languages
ISO 17100 · ISO 9001 · ISO 13485
Expert Human Quality Review
Terminology & Version Control

Consent Translation Has to Work for the Study—and for the Participant

An informed consent form is both an essential clinical trial document and a direct communication with prospective participants. Translation must preserve the meaning of the approved source while communicating naturally and clearly to the intended participant population.

Preserve Clinical Meaning

Risk descriptions, procedures, investigational treatments, visit schedules, medical terminology, randomization, participant responsibilities, and other study concepts need to retain the intent and distinctions established in the source ICF.

Support Participant Understanding

Clinical accuracy should not result in unnecessarily technical or unnatural language. Readability, sentence structure, terminology, local language conventions, and the intended audience all matter.

Prepare for Multilingual Review

Translated consent materials may move through sponsors, CROs, clinical sites, investigators, IRBs, ethics committees, legal or medical reviewers, and in-country teams. A controlled process helps keep comments, terminology decisions, and document versions organized.

Informed Consent and Related Participant Materials

Global consent workflows often involve more than a single master ICF. Sesen supports informed consent forms and related participant-facing materials that need to remain linguistically and operationally aligned throughout a clinical study.

Informed Consent Forms

Translation of master ICFs, country-specific consent forms, site-specific versions, and other informed consent documentation for multilingual clinical trials.

Assent Forms

Age-appropriate translation of assent materials used with pediatric and adolescent study participants, based on the source content and study requirements.

Re-Consent Materials

Translation and controlled updates when protocol amendments, new safety information, study changes, or other revisions require participants to receive updated consent information.

Patient Information Sheets

Clear translation of participant-facing information describing study purpose, procedures, expectations, visits, possible risks, and other study information.

Short-Form Consent Materials

Translation of short-form consent documents when they are part of the applicable institutional, IRB, ethics committee, or study-specific consent process.

Privacy and Authorization Materials

Translation of privacy notices, HIPAA authorization materials, data-use language, confidentiality provisions, and related participant documentation.

Electronic Consent Content

Localization of eConsent screens, participant instructions, interface text, prompts, help content, and supporting digital materials used in electronic consent workflows.

Caregiver and Legally Authorized Representative Materials

Translation of consent and explanatory materials intended for parents, guardians, caregivers, or legally authorized representatives where applicable.

A Controlled Workflow for Multilingual Informed Consent

Each study has its own language coverage, terminology, source-document history, review pathway, and delivery requirements. Sesen builds the ICF translation workflow around those study-specific needs while maintaining structured linguistic and quality controls.

01

Study and Source Review

We review the source ICF together with available study references, protocol terminology, previous translations, sponsor glossaries, formatting requirements, requested locales, reviewer instructions, and other relevant materials.

02

Terminology Alignment

Study-specific language is aligned with protocol terminology, approved glossaries, investigational product terminology, prior translations, and related participant-facing content.

03

Professional Translation

Qualified native-language linguists with relevant medical, clinical research, or life sciences expertise translate for meaning rather than mechanically reproducing source-language structure.

04

Independent Linguistic Review

A second qualified linguist reviews the translation against the source for accuracy, completeness, terminology, consistency, tone, and participant-facing clarity.

05

Quality and Readability Review

Document-level QA evaluates clinical meaning, completeness, numbers, dates, terminology, study identifiers, version references, formatting, and participant-facing readability.

06

Reviewer Coordination and Finalization

Authorized sponsor, CRO, site, IRB or ethics committee, medical, legal, and in-country feedback can be reconciled and incorporated into the appropriate language version.

Patient-Appropriate Language Without Changing the Meaning

ICFs frequently need to communicate sophisticated medical and clinical concepts to people who do not have a medical background. The goal is not to simplify important information away. It is to communicate the same information as clearly and naturally as the target language allows.

Additional verification when the study requires it

When requested by the sponsor, CRO, IRB, ethics committee, institution, or study quality plan, Sesen can incorporate independent back translation, reconciliation, in-country review, certificates of translation accuracy, or other defined QA steps.

When content is a COA, PRO, eCOA, or related clinical outcome instrument that requires formal validation, Sesen uses a separate linguistic validation workflow rather than treating linguistic validation as a routine ICF translation step.

Medical and Clinical Terminology

Technical terminology needs to remain accurate, but direct word-for-word translation is not always the clearest way to communicate a concept to participants.

Risks and Potential Benefits

Qualifiers, probability language, severity, uncertainty, and distinctions in risk and benefit statements require careful linguistic review.

Procedures, Visits, and Participant Responsibilities

Study procedures, treatment schedules, visit timing, randomization language, required activities, and participant obligations should remain aligned with the approved source.

Participant Rights and Choice

Language related to voluntary participation, withdrawal, confidentiality, alternatives, compensation, injury, data use, and study contacts needs to preserve the participant-facing meaning of the source.

Plain Language Without Meaning Loss

Readable translation is not the same as oversimplification. Sesen avoids unnecessarily complex or literal phrasing while maintaining clinical, ethical, and study-specific meaning.

Local Language Conventions

Sentence structure, terminology, forms of address, punctuation, register, and other language conventions can be adapted for the target population and project requirements.

Multilingual Study Control

Keep Every Consent Version Aligned as the Study Changes

The first translation is only one part of the ICF lifecycle. A multinational study may involve a master source ICF, country adaptations, site versions, multiple languages, reviewer feedback, protocol amendments, new safety information, and re-consent. Sesen treats these changes as a controlled multilingual content workflow.

Approved Study Content

Source and Terminology

Protocol, master ICF, approved terminology, study references, and the approved source version.

Multilingual Consent

Language Versions

Controlled target-language versions built from approved terminology and reusable study language assets.

Review Environment

Review and Feedback

Sponsor, CRO, site, investigator, IRB or ethics committee, medical, legal, and in-country review.

Change or Amendment

Identify What Changed

Analyze source changes and determine which content, documents, and language versions are affected.

Controlled Update

Update and Finalize

Translation update, review, QA, reviewer reconciliation, and clearly controlled final versions.

Translation Memory

Previously translated and approved content can be reused where appropriate to support consistency across versions and reduce unnecessary retranslation.

Terminology Governance

Study titles, product names, procedures, visits, participant groups, and other recurring concepts can be managed through study-specific glossaries and approved terminology.

Change Analysis

When the source changes, affected text can be identified so teams can determine which translated documents and language versions require attention.

Reviewer Decision Tracking

Approved terminology and linguistic decisions can be incorporated into project resources so the same issue does not need to be resolved repeatedly.

Cross-Document Consistency

Language can remain aligned across the ICF, protocol, patient information, recruitment materials, safety communication, eConsent, and other related study content.

Human Expertise at the Center of ICF Quality

Informed consent is patient-facing clinical content. The final interpretation of meaning, readability, tone, and appropriateness requires professional judgment. Sesen combines expert human translation and review with controlled language technology so each can do the work it is best suited to perform.

Professional Expertise

Life Sciences Linguists and Human Review

  • Qualified native-language translators
  • Clinical and medical subject-matter experience
  • Independent bilingual review
  • Terminology research and management
  • Patient-facing language judgment
  • Reviewer coordination and final human QA
Technology-Enabled Quality Control

Tools That Help Reviewers Focus Attention

  • Terminology consistency checks
  • Missing-content flags
  • Number, date, and unit comparisons
  • Repeated-text inconsistency detection
  • Formatting and version-difference checks
  • Cross-file consistency support
AI-assisted QA supports expert review. Final linguistic quality decisions remain under human oversight.

Support for Study Startup, Amendments, and Ongoing Consent Updates

Clinical study language needs do not always arrive on a predictable schedule. Sesen supports both planned multilingual study launches and the ongoing changes that arise as trials progress.

Study Startup

Coordinate translation across multiple target languages from an approved master source while establishing terminology and reusable language assets for the study.

Country and Site Expansion

Add new languages, locales, countries, or site-specific versions while maintaining consistency with translations already reviewed and approved.

Protocol and ICF Amendments

Identify changed content, update affected language versions, reuse approved terminology, and maintain clear connections to the applicable source version.

Safety-Related Updates

Support priority workflows when revised risks, safety information, participant instructions, or other time-sensitive content needs multilingual updates.

Re-Consent

Coordinate multilingual updates when participants need revised consent materials following study changes.

Reviewer-Driven Revisions

Incorporate authorized sponsor, CRO, site, IRB, ethics committee, or in-country feedback while keeping approved terminology and version history controlled.

Project schedules are based on source length, number of languages, required locales, review methodology, file format, documentation requirements, and study timeline. Parallel language production and priority workflows can be coordinated when the study schedule requires them.

Informed Consent Form Translation Across 150+ Languages

Sesen supports multilingual informed consent programs across major global research markets, including country- and region-specific language variants based on study requirements.

Language planning can account for participant population, study requirements, language and locale, regional terminology, existing approved translations, sponsor terminology, and reviewer preferences supplied for the project.

Centralized terminology, translation memory, reviewer feedback, and version control help multilingual programs stay aligned as countries and language coverage expand.

150+
languages supported for global life sciences programs
Europe Asia-Pacific Latin America Middle East & Africa North America Country & regional variants

Support Beyond the Consent Form

Informed consent sits within a larger clinical content ecosystem. Sesen helps study teams maintain consistency across patient-facing materials, clinical documentation, review content, and digital study experiences.

Practical Guidance for Multilingual ICF Programs

Sesen's clinical and regulatory knowledge resources help sponsors, CROs, and study teams plan translation, review, and quality-control decisions before they become downstream study issues.

Clinical & Regulatory Knowledge

Informed Consent Form Translation Best Practices for Sponsors and CROs

Practical guidance on participant readability, clinical meaning, local language conventions, reviewer coordination, terminology consistency, and version control.

Explore Resource
White Paper & Guide

Practical Implementation Guide to ICF Translation for Global Clinical Trials

A deeper guide to planning and managing informed consent translation across languages, countries, review workflows, and amendment cycles.

Explore Resource
Clinical & Regulatory Knowledge

Preparing Multilingual Materials for IRB and Ethics Committee Review

Source preparation, translation documentation, locale planning, participant readability, and multilingual version control for ethics review.

Explore Resource

Informed Consent Form Translation FAQs

Answers to common questions about multilingual informed consent translation, review, back translation, amendments, and global study support.

What is informed consent form translation?

Informed consent form translation is the translation of clinical trial consent documentation into languages participants can use to review study information and take part in the applicable consent process. It requires careful preservation of study procedures, potential risks and benefits, participant rights, privacy information, medical terminology, and other source content while producing clear, natural target-language communication.

When are translated informed consent forms needed?

Translated consent materials may be needed when a clinical study includes participants who require study information in another language or when the applicable sponsor, institution, IRB, ethics committee, site, or local study process calls for translated participant documentation. Requirements can vary by study, institution, market, participant population, and review pathway.

Who translates Sesen informed consent forms?

Sesen assigns qualified native-language linguists with relevant life sciences, medical, or clinical research expertise based on the language pair and project requirements. ICF workflows can also include independent linguistic review, document QA, terminology management, reviewer coordination, and final human quality control.

Does every ICF require back translation?

No. Back translation is an additional verification method rather than an automatic requirement for every informed consent translation. It may be requested by a sponsor, CRO, institution, IRB, ethics committee, local requirement, or study quality process.

Is linguistic validation required for informed consent forms?

Formal linguistic validation is generally associated with instruments such as clinical outcome assessments, patient-reported outcome measures, eCOAs, and ePROs where cross-language conceptual equivalence may need to be demonstrated through a defined validation methodology. ICF translation typically focuses on accurate translation, participant-appropriate readability, linguistic review, terminology consistency, document control, and the verification steps required by the specific study or review process.

How does Sesen handle ICF amendments?

Sesen can compare the updated source against the previous version, identify affected content, update the relevant language versions, reuse approved terminology and translation memory where appropriate, perform linguistic and document QA, and coordinate reviewer feedback.

Can Sesen incorporate IRB, ethics committee, site, or in-country reviewer comments?

Yes. Sesen can coordinate authorized multilingual reviewer feedback and help reconcile comments against the source, existing approved translations, and study terminology. Approved terminology and language decisions can then be incorporated into project linguistic assets for future versions.

Can Sesen translate assent forms and eConsent materials?

Yes. Sesen supports assent forms, re-consent materials, patient information sheets, privacy and authorization content, caregiver or legally authorized representative materials, and eConsent interfaces and supporting content.

How does Sesen maintain consistency between the ICF and other study documents?

Sesen can use protocols, sponsor glossaries, previous approved translations, study-specific terminology, translation memories, style guidance, and reviewer feedback as reference materials. Key concepts can then be managed consistently across the ICF and related participant-facing or clinical trial documentation.

How many languages does Sesen support for informed consent translation?

Sesen supports informed consent form translation across 150+ languages, including country- and region-specific language variants where appropriate for the study and participant population.

How quickly can Sesen translate an informed consent form?

Timelines depend on source length and complexity, language count and locales, file format, required review methodology, back translation or other verification requirements, formatting needs, reviewer cycles, and the study schedule. For multilingual study startup or time-sensitive amendments, Sesen can evaluate parallel production and priority workflows based on the required delivery sequence.

Planning Multilingual Consent for a Clinical Study?

Whether you are preparing a new global study, adding countries and languages, coordinating reviewer feedback, or managing an ICF amendment, Sesen can help build a controlled multilingual workflow around your study requirements.

Have final files and a defined language list? Request a quote. Planning a larger or recurring clinical program? Talk with Team Sesen.